Republicans want to abandon the bill altogether and Rep. Larry Buschon (R-Ind.) told The Hill he plans to propose a bill Friday to block the pilot.
Democrats in both the U.S. Senate and House have expressed concerns with the proposal as it exists. Democrats from the Senate Finance Committee wrote a letter to the administration expressing concerns the program could limit patient access to treatment, according to the report. House Democrats penned a similar letter expressing 11 chief concerns, including how it relates to rural providers, according to the report.
The proposal would change the way Medicare Part B reimburses providers for drugs. It currently pays providers the average price of a drug plus 6 percent. Under the proposed bill, the 6 percent would be reduced to 2.5 percent plus a $16 flat fee, according to The Hill.
HHS maintained its support for the bill despite Congressional concerns, according to the report.
More articles on finance:
Moody’s preliminary numbers show nonprofit healthcare profitability margins at multi-year high
Ochsner recognized for improvements implemented across spend and revenue cycle segments
No 2 prices the same: 13 findings on healthcare price variation across the U.S.